Showing 1 - 13 results of 13 for search 'Aafia Chaudhry', query time: 0.06s
Refine Results
-
1
PB2279: TRIAL IN PROGRESS: ODRONEXTAMAB, A CD20×CD3 BISPECIFIC ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MZL) – A COHORT FROM THE ELM... by Seok-Goo Cho, Tae Min Kim, Michał Taszner, Tsai Yun Chen, Aafia Chaudhry, Melanie Ufkin, Amulya Uppala, Ayesha Sabir, Hesham Mohamed, Srikanth Ambati, Emmanuel Bachy
Published 2023-08-01
Article -
2
PB2275: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHEMOTHERAPY VERSUS RITUXIMAB PLUS CHEMOTHERAPY IN PREVIOUSLY UNTREATED FOLLICULAR... by Silvana Novelli, Ashish Risal, Manjusha Namuduri, Jingxian Cai, Melanie Ufkin, Min Zhu, Sushmita Mukherjee, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Elżbieta Iskierka-Jażdżewska
Published 2023-08-01
Article -
3
PB2328: TRIAL IN PROGRESS: ATHENA-1 – A PHASE 1 STUDY TO ASSESS SAFETY AND TOLERABILITY OF REGN5837 IN COMBINATION WITH ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE... by Pim G. N. J. Mutsaers, Jeremy S. Abramson, Manjusha Namuduri, Jingjin LI, Nickolas A. Sophos, Min Zhu, Jurriaan Brouwer-Visser, Hesham Mohamed, Aafia Chaudhry, Andrew J. Davies
Published 2023-08-01
Article -
4
PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN... by Cecilia Carmen Carpio Segura, Manjusha Namuduri, Dishan Liu, Nickolas A. Sophos, Min Zhu, Ayesha Sabir, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Alejandro Martin Garcia-Sancho
Published 2023-08-01
Article -
5
PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) by Stefano Luminari, Tae Min Kim, Ashish Risal, Manjusha Namuduri, Jingxian Cai, Bertha Fearon-Chalet, Min Zhu, Sushmita Mukherjee, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Umberto Vitolo
Published 2023-08-01
Article -
6
PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYM... by Eliza A. Hawkes, Tae Min Kim, Manjusha Namuduri, Ashish Risal, Biyi Shen, Dina Flink, Min Zhu, Siobhán Nolan, Jurriaan Brouwer-Visser, Aafia Chaudhry, Srikanth Ambati, Hesham Mohamed, Seok-Goo Cho
Published 2023-08-01
Article -
7
PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (... by Benoit Tessoulin, Stephanie Guidez, Manjusha Namuduri, Ashish Risal3, Alpana Waldron, Nickolas A. Sophos, Amulya Uppala, Min Zhu, Siobhán Nolan, Jurriaan Brouwer-Visser, Aafia Chaudhry, Srikanth Ambati, Hesham Mohamed, David Tucker
Published 2023-08-01
Article -
8
PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA... by Umberto Vitolo, Elizabeth H. Phillips, Aránzazu Alonso Alonso, Michele Merli, Ashish Risal, Manjusha Namuduri, Biyi Shen, Dina Flink, Min Zhu, Sushmita Mukherjee, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Raul Cordoba
Published 2023-08-01
Article -
9
PB2281: TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN RELAPSED/REFRACTORY PATIENTS TREATED WITH SYSTEMIC THERAPY IN A REAL-WORLD ASSESSMENT (FLORA) by Gandhi Laurent Damaj, Emmanuel Bachy, Qiufei MA, Christian Hampp, James Harnett, Rachel E Sobel, Jessica J Jalbert, Ruben Gw Quek, Wenhui Wei, Ning Wu, Vera Mastey, Joy Wang, Anit Bajwa, Benedikt Maissenhaelter, Chantal van Gils, Shivani Aggarwal, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Catherine Thieblemont
Published 2023-08-01
Article -
10
PB2357: TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH SYSTEMIC THERAPY FROM REAL-WORLD EXPERIENCE (ORCHID) by Catherine Thieblemont, Qiufei MA, Christian Hampp, James Harnett, Rachel E Sobel, Jessica J Jalbert, Ruben Gw Quek, Wenhui Wei, Ning Wu, Vera Mastey, Joy Wang, Anit Bajwa, Benedikt Maissenhaelter, Chantal van Gils, Shivani Aggarwal, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Emmanuel Bachy, Gandhi Laurent Damaj
Published 2023-08-01
Article -
11
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractor... by Dina M Flink, Se Jeong, Gavin Thurston, Rajat Bannerji, Vladimir Jankovic, Nathalie Fiaschi, Max S Topp, Jurriaan Brouwer-Visser, Raquel P Deering, Kamil J Cygan, Darius Scott, Lauren Boucher, Namita T Gupta, Suraj Gupta, Christina Adler, Johannes Duell, Ranjana H Advani, Aafia Chaudhry, Srikanth R Ambati
Published 2024-03-01
Article -
12
P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 by Jan Walewski, Tae Min Kim, Seok-Goo Cho, Isidro Jarque, Elżbieta Iskierka-Jażdżewska, Michelle Poon, H. Miles Prince, Sung Yong Oh, Francesca Lim, Cecilia Carmen Carpio Segura, Tran-Der Tan, Sabarish Ayyappan, Antonio Gutiérrez, Jingjin LI, Melanie Ufkin, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Won-Seog Kim
Published 2023-08-01
Article -
13
P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 by Michał Taszner, Stefano Luminari, Seok-Goo Cho, Silvana Novelli, Steven Le Gouill, Michelle Poon, Jose Villasboas, Rebecca Champion, Emmanuel Bachy, Stephanie Guidez, Aránzazu Alonso Alonso, Deepa Jagadeesh, Michele Merli, David Tucker, Jingxian Cai, Carolina Leite de Oliveira, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Tae Min Kim
Published 2023-08-01
Article